研究结果:HIV PrEP队列(n=327)和HIV感染者队列(n=174)细菌性STI的相对风险(RR)均有所降低,包括淋病(RR 0.45,95%CI:0.34～0.65;RR 0.45,95%CI:0.34～0.65)、衣原体(RR 0.12,95%CI:0.05～0.25;RR 0.26,95%CI:0.12～0.57)和梅毒(RR 0.13,...
In Dec 2021, the CDC issued updated guidelines for HIV PrEP. Diagnostic panels were developed to facilitate the baseline evaluation and monitoring of patients for HIV, STIs, HBV, and HCV among PrEP users. METHODS. Retrospective analysis of results reported for HIV PrEP panels ordered between Feb...
爱家 数据科学 因为多次服用阻断药又不规律,感觉像是在prep和pep之间的状态,如果严格的话按prep,全网又找不到明确说多久可以排除的,只找英国标准中提到停止prep后45天这么一句话,但是他的依据是美国英国cdc标准中,99百分位在暴露后45天内可以检出来定的但是严格讲缺少一个数据!就是prep后停药的人和未prep人,两者...
吉列德科学和美CDC就HIV事先预防(PrEP)药的专利归属首次互撕在公堂!美CDC于2019就起诉吉列德科学没支付PrEP的2个口服药专利费,GILD对此说法坚决予以否认;CDC科学家在新的千禧第一个10年发现,2种抗艾药emtricitabine和tenofovir组合在一起,可高效预防HIV感染;吉列德科学的Truvada和Descovy均含emtricitabine/tenofovir,202...
继2012年在Truvada(舒发泰)被美国FDA批准为暴露前预防(PrEP)用药的2年之后,本周美国CDC的暴露前预防用药指南才姗姗来迟。在此我做个分享下载地址如下:如果百度能显示下载地址。。。http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf指南关键部分如下:(我作简要翻译)使用药物:指南推荐使用TDF/FTC 作为性...
"PrEP is a new approach to HIV prevention that requires continuing collaboration between patients and providers, as effectiveness requires adherence to daily medication and regular medical visits for monitoring, counseling and testing," Smith said. ...
The guidelines also highlight the importance of equitable distribution and access, which has limited the effectiveness of pre-exposure prophylaxis programs for HIV: According to the CDC, Black men and women account for approximately 40% of persons who qualify for PrEP, but only 13% of users are...
『科普』♀12-19..You can get or transmit HIV only through specific activities. Most commonly, people get or transmit
HIV infection; Infection risk behaviors during pregnancy; or International travel to regions with high or intermediate levels of endemic HBV infection. Some of these individuals — particularly those who are immunocompromised or who have end-stage renal disease — may warrant higher vaccine dosages tha...
HIV testing venues The potential impact of PrEP implementation at CDC-funded nonclinical HIV testing venuesThe potential impact of PrEP implementation at CDC-funded nonclinical HIV testing venuesVanessa M Kung